Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05483855Recruiting

Telehealth-delivered HealthcaRe to ImproVe Care

Role: lead

NCT04125459Active Not Recruiting

Assessing the Role of the NLRP3 Inflammasome in Intercritical Gout

Role: lead

NCT05627089Withdrawn

Rheumatoid Arthritis and Myositis Cohort

Role: lead

NCT03511625Phase 3Unknown

The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis

Role: lead

NCT05291299Not ApplicableUnknown

Anti-Inflammatory Dietary Intervention for Rheumatoid Arthritis

Role: lead

NCT03459274Unknown

Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology

Role: collaborator

All 6 trials loaded